The described invention provides kinase inhibiting compositions containing atherapeutic amount of a therapeuticinhibitor peptide that inhibits at least one kinase enzyme, methods fortreating an inflammatory disorder whose pathophysiologycomprises inflammatory cytokine expression, and methods for treating aninflammatory disorder whose pathophysiologycomprises inflammatory cytokine expression using the kinase inhibitingcompositions.
